These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24291495)

  • 1. Absence of C4d urinary excretion in the early post-transplant period is associated with improved long-term kidney graft survival.
    Zwiech R
    Transpl Immunol; 2014 Jan; 30(1):7-11. PubMed ID: 24291495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The early C4d urinary excretion and long-term kidney graft survival in patients treated with tacrolimus and mycophenolate mophetil].
    Zwiech R
    Pol Merkur Lekarski; 2014 Mar; 36(213):175-9. PubMed ID: 24779215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The assessment of C4d urinary excretion in early and late post kidney transplant periods].
    Zwiech R
    Wiad Lek; 2014; 67(1):3-6. PubMed ID: 25782209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Maintenance Immunosuppression Scheme Influences Early C4d Urinary Excretion in Kidney Graft Recipients but Does Not Affect the Long-term Graft Survival.
    Zwiech R
    Am J Ther; 2016; 23(3):e778-84. PubMed ID: 24777031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of pre-transplantation dialysis modality on late C4d urinary excretion in kidney graft recipients].
    Zwiech R
    Wiad Lek; 2014; 67(1):7-11. PubMed ID: 25782210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of maintenance immunosuppression scheme on D4d urinary excretion in kidney graft recipients].
    Zwiech R
    Wiad Lek; 2014; 67(4):476-80. PubMed ID: 26030951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive monitoring of renal transplant recipients: urinary excretion of soluble adhesion molecules and of the complement-split product C4d.
    Lederer SR; Friedrich N; Regenbogen C; Getto R; Toepfer M; Sitter T
    Nephron Clin Pract; 2003; 94(1):c19-26. PubMed ID: 12806188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejection.
    Vargha R; Mueller T; Arbeiter K; Regele H; Exner M; Csaicsich D; Aufricht C
    Pediatr Transplant; 2006 Jun; 10(4):449-53. PubMed ID: 16712602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis?
    Neves M; Cotovio P; Machado S; Santos L; Macário F; Alves R; Pratas J; Xavier da Cunha M; Mota A; Campos M
    Transplant Proc; 2012 Oct; 44(8):2360-5. PubMed ID: 23026593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
    Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW
    Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
    Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.
    Ho J; Wiebe C; Rush DN; Rigatto C; Storsley L; Karpinski M; Gao A; Gibson IW; Nickerson PW
    Transplantation; 2013 Feb; 95(4):595-602. PubMed ID: 23192155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure.
    Wang R; Wang H; Chen J; Wu J; Wang Y; Huang H; He Q
    Nephrology (Carlton); 2009 Aug; 14(5):527-32. PubMed ID: 19674321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4d as a significant predictor for humoral rejection in renal allografts.
    Jianghua C; Wenqing X; Huiping W; Juan J; Jianyong W; Qiang H
    Clin Transplant; 2005 Dec; 19(6):785-91. PubMed ID: 16313326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.
    Wu K; Budde K; Lu H; Schmidt D; Liefeldt L; Glander P; Neumayer HH; Rudolph B
    Transplantation; 2014 Jun; 97(11):1146-54. PubMed ID: 24892962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.
    Sharif A; Kraus ES; Zachary AA; Lonze BE; Nazarian SM; Segev DL; Alachkar N; Arend LJ; Bagnasco SM; Racusen LC; Montgomery RA
    Transplantation; 2014 Mar; 97(5):541-7. PubMed ID: 24521779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.